Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric Data

R, J, Kurman, H, J, Norris, Endometrial Hyperplasia and Related Cellular Changes, Blaustein's Pathology of the Female Genital Tract, 411, 437, Springer Verlag, New York Kurman, 1985, The behavior of endometrial hyperplasia: A long term study of “untreated” hyperplasia in 170 patients, Cancer, 56, 403, 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X Emons, 1993, High affinity binding and direct antiproliferative effects of LHRH analogues in human endometrial cancer cell lines, J Clin Endocrinol Metab, 77, 1458 Srkalovic, 1990, Detection and partial characterization of receptors for [d6, Cancer Res, 50, 1841 Ohno, 1993, Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma, Am J Obstet Gynecol, 169, 605, 10.1016/0002-9378(93)90630-2 Gallagher, 1991, A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue, Br J Obstet Gynaecol, 98, 1037, 10.1111/j.1471-0528.1991.tb15343.x De Vriese, 1993, Possible role of goserelin, an LH–RH agonist in the treatment of gynaecological cancers, Eur J Gynaecol Oncol, 14, 187 Garrow, 1985, Quetelet's index (W/H2, Int J Obes, 9, 147 Medicine, Institute of, Board, Food and Nutrition, Lactation, Committee on Nutritional Status during Pregnancy and Lactation. Nutrition during Pregnancy and, 1992, An Implementation Guide, National Academy Press, Washington DC Aufferman, 1984, Rapid diagnostic DNA cytometry with an automatic microscope and a TV image analysis system, Anal Quant Cytol, 6, 179 Boecking, 1987, Automated DNA cytophotometry, Lab Pract, 36, 73 Sandritter, 1966, Cytophotometric measurements of the DNA content of human malignant tumors by means of the Feulgen reaction, Acta Cytol, 10, 26 Boehm, 1968, Proportionalitaetsfehler bei der Feulgen-Hydrolyse, Histochemie, 15, 194, 10.1007/BF00305883 Graumann, 1983, Zur Standartisierung des Schiffschen Reagenz, Z Wiss Mikro, 51, 225 Auer, 1989 Boecking, 1984, Algorithm for a DNA cytophotometric diagnosis and grading of malignancy, Anal Quant Cytol, 6, 1 Boecking, 1986, Algorithm for DNA-cytophotometric diagnosis and grading of malignancy, Anal Quant Cytol, 6, 363 Aufferman, 1985, Early detection of precancerous lesions in dysplasias of the lung by rapid DNA image cytometry, Anal Quant Cytol, 7, 218 Ploem-Zaaijer, 1979, Cytofluorometric and Cytophotometric DNA Measurements of Cervical Smears Stained Using a New Bicolor Method, 225 Armitage, 1989 Altman, 1992 Gusberg, 1988, Diagnosis and Principles of Treatment of Cancer of the Endometrium, 337 Lobo, 1992, The role of progestins in hormone replacement therapy, Am J Obstet Gynecol, 166, 1997, 10.1016/0002-9378(92)91401-U Huber, 1966, Molekularbiologie fuer den Gynaekologen. Die Stickmonoxyd-Oestradiol-Achse, Speculum, 1, 19 Emons, 1994, The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers, Hum Reprod Update, 9, 1364, 10.1093/oxfordjournals.humrep.a138714 National Institutes of Health, National Institute of Aging, 1979, Estrogen Use in Postmenopausal Women, Consensus Conference on Aging Schulz, 1991, Palliative Hormonal Treatment in Endometrial Carcinoma, 119 Sasaki, 1993, Aromatase activities of endometrial carcinomas and both basic and clinical analyses of endometrial hyperplasia as a premalignant disease, Nippon Saka Fujinka Gakkai Zasshi, 45, 763 Pasqualini, 1996, Effect of decapeptyl (a GnRH analogue agonist) and of transforming growth factor-a, in the presence of heparin, on sulfatase activity in human breast cancer cells, Gynecol Endocrinol, 10, 66 Sismondi, 1994, Tamoxifen and endometrial cancer, Ann NY Acad Sci, 734, 310, 10.1111/j.1749-6632.1994.tb21761.x Terakawa, 1988, Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia, Cancer, 62, 2618, 10.1002/1097-0142(19881215)62:12<2618::AID-CNCR2820621228>3.0.CO;2-I Schally, 1989, The Use of LH–RH Analogs in Gynecology and Tumor Therapy, 3 Schally, 1989, Analogs of LH–RH: The Present and the Future, 5 Emons, 1992, Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonists in ovarian cancer, Acta Obstet Gynecol Scand, 71, 31, 10.1111/j.1600-0412.1992.tb00005.x Levy, 1993, A mechanism for direct growth inhibition of human breast and endometrial cancer cells by the GnRH antagonist, SB-75, Gynecol Endocrinol, 7, 26 Kullander, 1992, Treatment of endometrial cancer with GnRH analogs: Recent results, Cancer Res, 124, 69 Garozzo, 1993, Goserelin treatment in glandular hyperplasia, Clin Exp Obstet Gynecol, 20, 268 Pozzi, 1993, Treatment of endometrial hyperplasia with Goserelin depot, an LH–RH analog, Minerva Ginecol, 45, 312 Vitale, 1994, Anomalous uterine bleeding in the perimenopause: Fibromatosis, hyperplastic endometriopathy and GnRH analogs, Minerva Ginecol, 46, 317 Lopez de la Osa Gonzalez, 1994, Clinical response of abnormal endometrial growth to hormonal treatment, Ann NY Acad Sci, 734, 306, 10.1111/j.1749-6632.1994.tb21760.x Bulletti, 1996, The Use of GnRH Analog in Dysfunctional Uterine Bleeding, 233 Bonfirraro, 1995, Use of a GnRH analogue in the treatment of some forms of endometrial hyperplasia associated with menometrorrhagia, Minerva Ginecol, 47, 467 Menozzi, 1992, The use of leuprolide in endometrial glandular hyperplasia, Minerva Ginecol, 44, 383 Zagni, 1993, Therapy of simple endometrial hyperplasia with GnRH analogs: Evaluation of a multicentric ambulatory study. Preliminary results, Minerva Ginecol, 45, 597 Colacurci, 1991, The use of GnRH agonists for the treatment of dysfunctional uterine bleeding, Acta Eur Fertil, 22, 229 Pace, 1994, Low-risk endometrial hyperplasia: Hysteroscopy and histologic evaluation after treatment with LH–RH analogue, Clin Exp Obstet Gynecol, 21, 79 Rullo, 1991, Sonographic, hysteroscopic, histological correlation in the early diagnosis of endometrial carcinoma, Eur J Gynaecol Oncol, 6, 463 Beckner, 1985, Endometrial carcinoma: nontumor factors in prognosis, Int J Gynecol Pathol, 4, 131, 10.1097/00004347-198506000-00005 Deligdisch, 1985, Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia, Cancer, 56, 1452, 10.1002/1097-0142(19850915)56:6<1452::AID-CNCR2820560637>3.0.CO;2-D Barrett, 1995, Endometrial cancer: Stage at diagnosis and associated factors in black and white patients, Am J Obstet Gynecol, 173, 414, 10.1016/0002-9378(95)90261-9 Delgado, 1984, Feulgen cytophotometric analysis of single cells isolated from paraffin-embedded tissue, Pathol Res Pract, 179, 92, 10.1016/S0344-0338(84)80067-9 Boecking, 1995, Consensus report of the European Society for Analytical Cellular Pathology, task force on standardization of diagnostic DNA image cytometry, Anal Quant Cytol Histol, 17, 1 Moberger, 1984, The prognostic significance of DNA measurements in endometrial carcinoma, Cytometry, 5, 430, 10.1002/cyto.990050422 Fu, 1985, Ploidy measurement in tissue sections, Anal Quant Cytol, 7, 90 Wagner, 1967, Deoxyribonucleic acid content of presumed precursors of endometrial carcinoma, Cancer, 20, 2067, 10.1002/1097-0142(196712)20:12<2067::AID-CNCR2820201203>3.0.CO;2-C Hustin, 1976, Morphology and DNA content of endometrial cancer nuclei under progestogen treatment, Acta Cytol, 20, 556 Moberger, 1989 Punnonen, 1993, DNA ploidy, cell proliferation and steroid hormone receptor in endometrial hyperplasia and early adenocarcinoma, J Cancer Res Clin Oncol, 119, 426, 10.1007/BF01218425 Kysela, 1990, Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma, Neoplasma, 37, 489 Lindahl, 1991, Flow cytometrical DNA measurements in endometrial hyperplasias: A prospective follow-up study after abrasio only in additional high-dose gestagen treatment, Anticancer Res, 11, 391 Dallenbach-Hellweg, 1987 Agorastos, 1994, Minimal deviation adenocarcinoma of the cervix: A hypodiploid tumor?, Int J Gynecol Pathol, 13, 211, 10.1097/00004347-199407000-00004 Boecking, 1990, DNA Zytometrie und Automation in der klinischen Diagnostik, Beitr Onkol, 38, 298 Artacho-Perula, 1994, Application of the image analysis system and image program to biological samples, Res Exp Med Berl, 194, 35, 10.1007/BF02576364 Baak, 1995, Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up, Int J Gynecol Cancer, 5, 112, 10.1046/j.1525-1438.1995.05020112.x Benagiano, 1993, GnRH Analogues in the Management of Uterine Leiomyomas and Other Benign Gynecological situations, 55